BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15982318)

  • 1. Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature.
    Varma M; Jasani B
    Histopathology; 2005 Jul; 47(1):1-16. PubMed ID: 15982318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
    Jiang Z; Woda BA; Wu CL; Yang XJ
    Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma.
    Kunju LP; Mehra R; Snyder M; Shah RB
    Am J Clin Pathol; 2006 May; 125(5):675-81. PubMed ID: 16707367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
    Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
    Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
    J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma.
    Downes MR; Torlakovic EE; Aldaoud N; Zlotta AR; Evans AJ; van der Kwast TH
    J Clin Pathol; 2013 Sep; 66(9):779-86. PubMed ID: 23775437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry in diagnostic surgical pathology of the prostate.
    Hameed O; Humphrey PA
    Semin Diagn Pathol; 2005 Feb; 22(1):88-104. PubMed ID: 16512601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
    Stewart J; Fleshner N; Cole H; Toi A; Sweet J
    J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Markers for diagnosis, prediction and prognosis of prostate cancer].
    Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Achievements in morphological diagnosis of prostatic cancer: alpha-methylacyl-coenzyme-A-racemase--a new marker of malignant cell transformation].
    Pozharisskiĭ KM; Leenman EE; Arzumanov AA
    Arkh Patol; 2005; 67(5):15-9. PubMed ID: 16323473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma.
    Cossu-Rocca P; Contini M; Brunelli M; Festa A; Pili F; Gobbo S; Eccher A; Mura A; Massarelli G; Martignoni G
    Am J Surg Pathol; 2009 Jul; 33(7):1031-6. PubMed ID: 19384190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
    Kunju LP; Chinnaiyan AM; Shah RB
    Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.
    Trpkov K; Bartczak-McKay J; Yilmaz A
    Am J Clin Pathol; 2009 Aug; 132(2):211-20; quiz 307. PubMed ID: 19605815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical pitfalls in prostate pathology.
    Brimo F; Epstein JI
    Hum Pathol; 2012 Mar; 43(3):313-24. PubMed ID: 22325142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
    Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A
    Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.